Article
Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts.
American journal of human genetics - 3 Oct 2013
Aufenvenne Karin, Larcher Fernando, Hausser Ingrid, Duarte Blanca, Oji Vinzenz, Nikolenko Heike, Del Rio Marcela, Dathe Margitta, Traupe Heiko
Abstract excerpt
Transglutaminase-1 (TG1)-deficient autosomal-recessive congenital ichthyosis (ARCI) is a rare and severe genetic skin disease caused by mutations in TGM1. It is characterized by collodion babies at birth, dramatically increased transepidermal water loss (TEWL), and lifelong pronounced scaling. The disease has a tremendous burden, including the problem of stigmatization. Currently, no therapy targeting the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
